Glyprovac (private company)
See something wrong or missing? Let us know
Offices:Odense
Industry:BiotechHealth services
Business model:B2B
GlyProVac is a biotech startup in Denmark developing a platform technology, BEMAP, which discovered that 1) O-linked protein glycosylation is a surprisingly abundant post translational modification in bacterial, 2) glycoproteins are linked to increased immunogenicity.
values in USD
Investments 1.29M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Glyprovac
Name | Criteria | |
---|---|---|
![]() |
APIM Therapeutics
42%
|
|
![]() |
AptaTargets
42%
|
|
![]() |
Athera
42%
|
|
![]() |
AttgeNO
42%
|
|
![]() |
Bio-Me
42%
|
|
![]() |
Biomes
42%
|
|
![]() |
Bionomous
42%
|
|
![]() |
Biotts
42%
|
|
![]() |
Cebiotex
42%
|
|
![]() |
Celluminova
42%
|
|